logo

For the Inventor, By the Inventor

Bethlehem, NY, United States of America

Robert L Clarke

USPTO Granted Patents = 13

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 46(Granted Patents)


Location History:

  • Delmar, NY (US) (1980)
  • Bethlehem, NY (US) (1976 - 1983)

Company Filing History:

goldMedal13 out of 692 
 
Sterling Drug Inc.
 patents

Years Active: 1976-1983

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4396609 - Aminocyclitol antibiotics, pharmaceutical compositions and method of (1983-08-02),
2. 4379936 - Nortropane derivatives (1983-04-12),
3. 4341895 - Tropane derivatives (1982-07-27),
4. 4281130 - Lower-alkyl (1981-07-28),
5. 4233449 - 1-(8-Methyl-2-phenyl(or thienyl)-8-azabicyclo[3.2.1]octan-3-yl) ethanone (1980-11-11),
6. 4233448 - 3-Methoxycarbonyl-2-(2-thienyl)-8-azabicyclo[3.2.1]octane-8-acetamide (1980-11-11),
7. 4214084 - Ethanopyrrolo[1,2-b]isoquinolines (1980-07-22),
8. 4179567 - 2-Aryltropane compounds (1979-12-18),
9. 4028188 - Aminocyclitol antibiotics (1977-06-07),
10. 3992437 - Polyhydrophenanthrene derivatives (1976-11-16),
11. 3982996 - Process for preparing aminocyclitol antibiotics (1976-09-28),
12. 3972930 - Aminocyclitol antibiotics (1976-08-03),
13. 3932482 - Polyhydro-2-phenanthrylideneacetic acids and esters thereof (1976-01-13),

Title: The Innovative Journey of Robert L Clarke

Introduction

Robert L Clarke, an accomplished inventor based in Bethlehem, NY, has made significant contributions to the field of pharmaceuticals. With a prolific portfolio comprising 13 patents, Clarke’s work particularly focuses on developing innovative antibiotics and analgesics that have the potential to transform medical treatments.

Latest Patents

Clarke's most recent patents include advancements in aminocyclitol antibiotics and complex pharmaceutical compositions. One notable invention involves the preparation of aminocyclitol analogs of gentamicin, which entails a detailed process of culturing a nutrient medium with specific carbohydrates, nitrogen sources, and essential salts alongside a mutant of Micromonospora purpurea. This innovative method showcases Clarke's expertise in both microbiology and pharmaceutical chemistry. Another significant patent revolves around nortropane derivatives, specifically 3.alpha.-benzoylamino-2.beta.-hydroxy-nortropanes. These compounds, which are enhanced with alkoxycarbonyl or alkanoyl groups, are recognized for their utility as effective analgesics. The preparation of these derivatives involves a sophisticated reaction with benzylamine and phenol, highlighting the inventive techniques employed by Clarke.

Career Highlights

Clarke’s career has been marked by his tenure at Sterling Drug Inc., where he has had the opportunity to bring his innovative ideas to fruition. His dedication to advancing pharmaceutical science has positioned him as a notable figure in the industry, earning respect from colleagues and peers alike.

Collaborations

Throughout his career, Clarke has collaborated with esteemed colleagues, including Sol J Daum and Philip E Shaw. These partnerships have fostered a rich exchange of ideas and expertise, contributing to the successful development of Clarke’s patents and enhancing his contributions to pharmaceutical research.

Conclusion

Robert L Clarke exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive portfolio of patents, he continues to pave the way for new therapeutic advancements. His dedication to enhancing healthcare through innovative drug development demonstrates the impact that a single inventor can have on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…